1705 studies found for:    pancreatic cancer
Show Display Options
Rank Status Study
21 Not yet recruiting BrUOG 292: FOLFOX-A For Metastatic Pancreatic Cancer: A Phase II Brown University Oncology Research Group Trial
Condition: Metastatic Pancreatic Cancer
Intervention: Drug: FOLFOXA
22 Recruiting Mirtazapine Plus Gemcitabine Versus Gemcitabine in Metastasis Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Drug: Mirtazapine plus gemcitabine;   Drug: Gemcitabine, placebo
23 Active, not recruiting Pancreatic Cancer Genetic Epidemiology (PACGENE) Study
Condition: Pancreatic Cancer
Intervention: Behavioral: Questionnaire
24 Terminated Study With Gemcitabine and RTA 402 for Patients With Unresectable Pancreatic Cancer
Conditions: Pancreatic Neoplasms;   Pancreatic Cancer
Intervention: Drug: RTA 402
25 Terminated A Pilot Study, Evaluating the Efficacy of Regulatory T-cell Suppression by Ontak in Metastatic Pancreatic Cancer
Condition: Metastatic Pancreatic Cancer
Intervention: Drug: Ontak
26 Recruiting Neoadjuvant FIRINOX for Borderline Resectable Pancreatic Cancer - a Pilot Study
Condition: Pancreatic Cancer.
Intervention: Drug: FIRINOX
27 Recruiting Dose Escalation Study of OMP-54F28 in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Stage IV Pancreatic Cancer
Conditions: Pancreatic Cancer;   Stage IV Pancreatic Cancer
Intervention: Drug: OMP-54F28, Nab-Paclitaxel and Gemcitabine
28 Recruiting A Study of Vantictumab (OMP-18R5) in Combination With Nab-Paclitaxel and Gemcitabine in Previously Untreated Stage IV Pancreatic Cancer
Conditions: Pancreatic Cancer;   Stage IV Pancreatic Cancer
Interventions: Drug: Vantictumab;   Drug: Nab-Paclitaxel;   Drug: Gemcitabine
29 Recruiting BrUOG 278: FOLFOX-A For Pancreatic Cancer A Brown University Oncology Research Group Study
Condition: Metastatic Pancreatic Cancer
Intervention: Drug: FOLFOX-A
30 Recruiting Gemcitabine+Nab-paclitaxel and FOLFIRINOX and Molecular Profiling for Patients With Advanced Pancreatic Cancer
Condition: Stage IV Pancreatic Cancer
Interventions: Drug: Gemcitabine;   Drug: nab-paclitaxel;   Drug: FOLFIRINOX;   Genetic: Immunohistochemistry (IHC) Analysis;   Drug: Metformin;   Drug: mFOLFIRI
31 Recruiting Pancreatic Cancer Early Detection Program
Conditions: Pancreatic Cancer;   Pancreas Cancer;   Pancreatic Adenocarcinoma;   Familial Pancreatic Cancer;   BRCA 1/2;   HNPCC;   Lynch Syndrome;   Hereditary Pancreatitis;   FAMMM;   Familial Atypical Multiple Mole Melanoma;   Peutz Jeghers Syndrome
Interventions: Procedure: Endoscopic Ultrasound;   Procedure: Magnetic Resonance Imaging (MRI)
32 Completed Identification of Biomarkers for Early Detection of Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Genetic: protein expression analysis;   Other: laboratory biomarker analysis;   Other: mass spectrometry;   Other: surface-enhanced laser desorption/ionization-time of flight mass spectrometry
33 Recruiting Functional Magnetic Resonance Imaging of Pancreatic Cancer: a Feasibility and Reproducibility Study
Condition: Pancreatic Cancer
Intervention: Drug: Gadobutrol
34 Enrolling by invitation A Phase III Study of Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention:
35 Unknown  Human Leukocyte Antigen-A*2402-Restricted Tumor Vessel Specific Peptide Vaccination for Advanced Pancreatic Cancer
Conditions: Pancreatic Cancer;   Pancreas Neoplasms
Intervention: Biological: VEGFR1-A24-1084 (SYGVLLWEI)
36 Completed Gemcitabine With or Without Tipifarnib (R115777) in Treating Patients With Advanced Pancreatic Cancer
Condition: Pancreatic Neoplasms
Interventions: Drug: Gemcitabine with R115777;   Drug: Gemcitabine with Placebo
37 Active, not recruiting Detection of Peritoneal Micrometastasis in Gastric and Pancreatic Cancer in Peritoneal Wash Samples
Condition: Gastric and Pancreatic Cancer
Intervention: Other: washings for experimental marker testing
38 Completed Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer
Condition: Metastatic Pancreatic Cancer
Interventions: Biological: bavituximab;   Drug: Gemcitabine
39 Completed Assessment Of Stromal Response To Nab-Paclitaxel In Combination With Gemcitabine In Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention: Drug: Gemcitabine plus nab-paclitaxel
40 Recruiting Metformin Hydrochloride in Treating Patients With Pancreatic Cancer That Can be Removed by Surgery
Conditions: Stage IA Pancreatic Cancer;   Stage IB Pancreatic Cancer;   Stage IIA Pancreatic Cancer;   Stage IIB Pancreatic Cancer
Interventions: Drug: metformin hydrochloride;   Other: pharmacological study

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years